MeSH tree: D06.472.699.587.200.300.100
California will start selling low-cost insulin on Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make lifesaving medications more affordable for folks with diabetes.
Oct 20, 2025
0
13
Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated hemoglobin (HbA1c) among adults with type 2 diabetes, according to a study published online June ...
Jun 27, 2025
0
16
After publishing research in 2022 that compared the effectiveness of four common medications for type 2 diabetes, University of Colorado Department of Medicine faculty member Neda Rasouli, MD, and a national team of researchers ...
Jul 23, 2024
0
61
Diabetes affects more than 1 in 10—or more than 38 million—Americans. People with diabetes who keep their blood sugar levels in the near-normal range generally have a much lower risk of developing diabetes complications such ...
Mar 26, 2024
0
45
Managing diabetes will be a less expensive proposition for more Americans in 2024.
Jan 2, 2024
0
69
Over the last four decades, insulin manufacturers have extended their periods of market exclusivity on brand-name insulin products by employing several strategies, including filing additional patents on their products after ...
Nov 16, 2023
0
73
For adults with type 2 diabetes, glycemic control is significantly better with once-weekly icodec than once-daily insulin glargine U100, according to a study published online June 24 in the New England Journal of Medicine ...
Jun 26, 2023
0
30
U.S. insulin prices substantially increased from 2012 to 2015; however, the introduction of new products has led to substantial discounting practices and lower net prices, according to a study published online June 16 in ...
Jun 16, 2023
0
43
French pharmaceutical giant Sanofi announced on Thursday it would cut the US price of its most prescribed insulin by 78 percent, falling in line with two other major drug makers.
Mar 17, 2023
0
41
In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide performed the best of four medications approved by the U.S. Food ...
Sep 21, 2022
0
140
